Israel Active

Israeli and US researchers have discovered that gentle stimulation of part of the brain improves the ability of seniors to perform multiple tasks. The study of 57 subjects aged over 70 improved simultaneous walking and talking, thus reducing their risk of having a fall.

Israel’s DarioHealth (see previously) is to provide remote patient monitoring services to one of the largest providers in Hawaii. It also has won a contract with a primary care system in Atlanta Georgia with multiple locations. All these patients live with diabetes and/or hypertension.

In August, the Galilee Medical Center delivered a baby at 35 weeks when his unvaccinated Arab mother, Mira, suffered respiratory failure and pneumonia from Covid-19. After months of treatment and rehabilitation, Mira has just been discharged, thanking staff for two gifts - her life and her baby.

Asaf Zviran co-founded Israel’s C2i Genomics (see previously). It has developed a blood test that can identify whether a cancer patient will survive after the tumor has been completely removed, or whether further chemotherapy is necessary.

The number of serious Covid cases in Israel is now under 400 (mostly unvaccinated) and several hospitals have closed their Covid wards. Over 3.8 million Israelis have now had the booster vaccination. The government plans to allow in fully vaccinated, individual tourists from 40 countries from late November.

Scientists from Tel Aviv University and North America used phosphorus and calcium markers to monitor brain patterns in rats when they go to the aid of a trapped member of their breed. A neural network activates in a similar way to when they are given a chocolate reward.

In its annual list of the World’s Best Specialized Hospitals, Newsweek magazine ranked Israel’s Sheba Medical Center number 40 for neurosurgery, 42 for cardiology care and 44 for gastroenterology. See for previous top Newsweek rankings for Sheba.

Israel’s Sagol Center at Shamir Medical Center is the world’s largest hyperbaric medicine and research facility. Israel’s Aviv Scientific has partnered with Sagol to provide personalized cognitive and physical HBOT training. It also has clinics in Florida and Dubai.

Dr Ludwik Fleck, who fled to Israel from Poland in 1957, made a groundbreaking discovery of a vaccine for typhus whilst a prisoner in the Nazi’s Buchenwald concentration camp during WWII. He managed to fool the Nazis and vaccinated many thousands of Jews.

Israel’s CytoReason (see previously) has added SPI (part of Japanese giant Sumitomo) to its growing list of partners.  SPI will use CytoReason’s unique immune focused machine learning platform and represent CytoReason in the Japanese market - the third largest globally.